Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease
Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease
Recruiting · NCT06071429 · Registry updated 2026-02-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease | Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Not applicable | 2026-02-06 | NCT06071429 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| R3 Vascular Inc. | 3 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CUMC/NYP | New York | United States | 1 |
| NYU Langone Health | New York | United States | 403 |
| Staten Island University Hospital - Northwell Health | Staten Island | United States | 1 |